Objective:

To evaluate medication adherence in patients with chronic uveitis using the MARS-5 scale and investigate barriers to adherence, emphasizing the importance of these barriers in treatment outcomes.

Approach:

Key Findings:

• Medication adherence was assessed using the MARS-5 scale, with higher scores indicating better adherence. Specific adherence rates should be included.
• A questionnaire identified common barriers to adherence, including treatment beliefs, motivation, and medication costs.

Interpretation:

Understanding adherence levels and barriers is crucial for optimizing treatment strategies in chronic uveitis patients.

Limitations:

• The study was conducted at a single center, which may limit generalizability. This limitation could affect the applicability of findings to broader populations.
• The adherence barrier questionnaire was not psychometrically validated, which may impact the reliability of the identified barriers.

Conclusion:

Improving patient education and addressing barriers can enhance adherence and clinical outcomes in chronic uveitis management.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.